Unprotected sex among HIV-positive injection drug-using women and their serodiscordant male partners: Role of personal and partnership influences

Journal of Acquired Immune Deficiency Syndromes

Volumn 42, Issue 2, 2006, Pages 222-228

  Latka, Mary H ^a,b   Metsch, Lisa R ^c   Mizuno, Yulo ^d   Tobin, Karin ^e   Mackenzie, Sonia ^f   Arnsten, Julia H ^g   Gourevitch, Marc N ^h  

^a NEW YORK ACADEMY OF MEDICINE   (United States)

^b UNIVERSITY OF KWAZULU NATAL   (South Africa)

^c UNIVERSITY OF MIAMI   (United States)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^e JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^h NEW YORK UNIVERSITY   (United States)

Author keywords

Condom use; HIV; Injection drug user; Serodiscordant; Sexual risk behavior; Women

Indexed keywords

ADDICTION; ADULT; ARTICLE; CONDOM; CONTRACEPTION; CONTROLLED STUDY; DRUG USE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; RESPONSIBILITY; RISK ASSESSMENT; SEXUAL BEHAVIOR; SEXUAL INTERCOURSE; SEXUAL TRANSMISSION; SEXUALITY;

ADULT; ATTITUDE; CONDOMS; FEMALE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; SEXUAL BEHAVIOR; SEXUAL PARTNERS; SOCIOECONOMIC FACTORS; SUBSTANCE ABUSE, INTRAVENOUS; UNSAFE SEX;

EID: 33745099281     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.qai.0000214813.50045.09     Document Type: Article

References (52)

1. Advancing HIV prevention: new strategies for a changing epidemic - United States, 2003. MMWR Morb Mortal Wkly Rep. 2003;52:329-332.
2. Incorporating HIV prevention into the medical care of persons living with HIV. Recommendations of CDC, the Health Resources and Services Administration, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. MMWR Recomm Rep. 2003;52:1-24.
3. Janssen RS, Valdiserri RO. HIV prevention in the United States: increasing emphasis on working with those living with HIV. J Acquir Immune Defic Syndr. 2004;37(suppl 2):S119-S121.
4. Kral AH, Bluthenthal RN, Lorvick J, et al. Sexual transmission of HIV-1 among injection drug users in San Francisco, USA: risk-factor analysis. Lancet. 2001;357:1397-1401.
5. Strathdee SA, Sherman SG. The role of sexual transmission of HIV infection among injection and non-injection drug users. J Urban Health. 2003;80:iii7-iii14.
6. Centers for Disease Control and Prevention. HIV/AIDS Surveillance Report, 2003. Department of Health and Human Services, Centers for Disease Control and Prevention 15, 2004.
7. de Vincenzi I. A longitudinal study of human immunodeficiency virus transmission by heterosexual partners. European Study Group on Heterosexual Transmission of HIV. N Engl J Med. 1994;331:341-346.
8. Pinkerton SD, Abramson PR, Kalichman SC, et al. Secondary HIV transmission rates in a mixed-gender sample. Int J STD AIDS. 2000;11:38-44.
9. Celentano DD, Galai N, Sethi AK, et al. Time to initiating highly active antiretroviral therapy among HIV-infected injection drug users. AIDS. 2001;15:1707-1715.
10. Quinn TC, Wawer MJ, Sewankambo N, et al. Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group. N Engl J Med. 2000;342:921-929.
11. Heard I, Potard V, Costagliola D, et al. Contraceptive use in HIV-positive women. J Acquir Immune Defic Syndr. 2004;36:714-720.
12. Skurnick JH, Kennedy CA, Perez G, et al. Behavioral and demographic risk factors for transmission of human immunodeficiency virus type 1 in heterosexual couples: report from the Heterosexual HIV Transmission Study. Clin Infect Dis. 1998;26:855-864.
13. Diaz T, Schable B, Chu SY. Relationship between use of condoms and other forms of contraception among human immunodeficiency virus-infected women. Supplement to HIV and AIDS Surveillance Project Group. Obstet Gynecol. 1995;86:277-282.
14. Dolezal C, Ehrhardt AA, Meyer-Bahlburg HF, et al. Sexual risk behavior changes among HIV+ and HIV- female injecting drug users over 4 years. Women Health. 1998;27:1-17.
15. Wilson TE, Koenig L, Ickovics J, et al. Contraception use, family planning, and unprotected sex: few differences among HIV-infected and uninfected postpartum women in four US states. J Acquir Immune Defic Syndr. 2003;33:608-613.
16. Timpson SC, Williams ML, Bowen AM, et al. Condom use behaviors in HIV-infected African American crack cocaine users. Subst Abus. 2003;24:211-220.
17. Buchacz K, van der SA, Saul J, et al. Sociodemographic, behavioral, and clinical correlates of inconsistent condom use in HIV-serodiscordant heterosexual couples. J Acquir Immune Defic Syndr. 2001;28:289-297.
18. Wilson TE, Massad LS, Riester KA, et al. Sexual, contraceptive, and drug use behaviors of women with HIV and those at high risk for infection: results from the Women's Interagency HIV Study. AIDS. 1999;13:591-598.
19. Campsmith ML, Nakashima AK, Jones JL. Association between crack cocaine use and high-risk sexual behaviors after HIV diagnosis. J Acquir Immune Defic Syndr. 2000;25:192-198.
20. Parsons JT, Missildine W, Van OJ, et al. HIV serostatus disclosure to sexual partners among HIV-positive injection drug users. AIDS Patient Care STDs. 2004;18:457-469.
21. Bedimo AL, Bennett M, Kissinger P, et al. Understanding barriers to condom usage among HIV-infected African American women. J Assoc Nurses AIDS Care. 1998;9:48-58.
22. Hetherington SE, Harris RM, Bausell RB, et al. AIDS prevention in high-risk African American women: behavioral, psychological, and gender issues. J Sex Marital Ther. 1996;22:9-21.
23. Lansky A, Nakashima AK, Jones JL. Risk behaviors related to heterosexual transmission from HIV-infected persons Supplement to HIV/AIDS Surveillance Study Group. Sex Transm Dis. 2000;27: 483-489.
24. Crepaz N, Marks G. Towards an understanding of sexual risk behavior in people living with HIV: a review of social, psychological, and medical findings. AIDS. 2002;16:135-149.
25. Kirshenbaum SB, Hirky AE, Correale J, et al. "Throwing the dice": pregnancy decision-making among HIV-positive women in four U.S. cities. Perspect Sex Reprod Health. 2004;36:106-113.
26. Kalichman SC, Rompa D, Luke W, et al. HIV transmission risk behaviours among HIV-positive persons in serodiscordant relationships. Int J STD AIDS. 2002;13:677-682.
27. Purcell DW, Metsch LR, Latka M, et al. Interventions for seropositive injectors-research and evaluation: an integrated behavioral intervention with HIV-positive injection drug users to address medical care, adherence, and risk reduction. J Acquir Immune Defic Syndr. 2004;37:S110-S118.
28. Mills S, Saidel T, Magnani R, et al. Surveillance and modelling of HIV, STI, and risk behaviours in concentrated HIV epidemics. Sex Transm Infect. 2004;80(suppl 2):ii57-ii62.
29. Derogatis LR, Spencer PM. Brief Symptoms Inventory. Baltimore, MD: John Wiley & Sons, 1982.
30. O'leary A, Wolitski RJ, Remien RH, et al. Psychosocial correlates of transmission risk behavior among HIV-seropositive gay and bisexual men. AIDS. 2005;19:S67-S75.
31. Wolitski RJ, Bailey CJ, O'leary A, et al. Self-perceived responsibility of HIV-seropositive men who have sex with men for preventing HIV transmission. AIDS Behav. 2003;7:363-372.
32. Rogers ES, Chamberlin J, Ellison ML, et al. A consumer-constructed scale to measure empowerment among users of mental health services. Psychiatr Serv. 1997;48:1042-1147.
33. Fishbein M, Middlestadt SE, Trafimow D. Social norms for condom use: implications for HIV prevention interventions of a KABP survey with heterosexuals in the Eastern Caribbean. Adv Consum Res. 1993;20:292-296.
34. Straus M. Measuring intrafamily conflict and violence: the Conflict Tactics (CT) scales. J Marriage Fam. 1979;41:75-88.
35. Barrera MA. A method for assessing social support networks in community survey research. Connections. 1980;3:8-13.
36. Tross S. Women at heterosexual risk for HIV in inner-city New York: reaching the hard to reach. AIDS Behav. 2001;5:131-139.
37. Laumann EO, Youm Y. Racial/ethnic group differences in the prevalence of sexually transmitted diseases in the United States: a network explanation. Sex Transm Dis. 1999;26:250-261.
38. Grella CE, Campos M, Anglin MD. Relationship of HIV testing and high-risk behaviors among clients in methadone maintenance treatment. AIDS Educ Prev. 1998;10:403-416.
39. Nelson KE, Galai N, Safaeian M, et al. Temporal trends in the incidence of human immunodeficiency virus infection and risk behavior among injection drug users in Baltimore, Maryland, 1988-1998. Am J Epidemiol. 2002;156:641-653.
40. Bogart LM, Kral AH, Scott A, et al. Sexual risk among injection drug users recruited from syringe exchange programs in California. Sex Transm Dis. 2005;32:27-34.
41. HIV transmission risk behavior among men and women living with HIV in 4 cities in the United States. J Acquir Immune Defic Syndr. 2004;36:1057-1066.
42. Wingood GM, DiClemente RJ, Mikhail I, et al. A randomized controlled trial to reduce HIV transmission risk behaviors and sexually transmitted diseases among women living with HIV: the WiLLOW Program. J Acquir Immune Defic Syndr. 2004;37:S58-S67.
43. Wolitski RJ, Parsons JT, Gomez CA. Prevention with HIV-seropositive men who have sex with men: lessons from the Seropositive Urban Men's Study (SUMS) and the Seropositive Urban Men's Intervention Trial (SUMIT). J Acquir Immune Defic Syndr. 2004;37:S101-S109.
44. Dancy BL, Berbaum ML. Condom use predictors for low-income African American women. West J Nurs Res. 2005;27:28-44.
45. Crosby RA, DiClemente RJ, Wingood GM, et al. HIV/STD prevention benefits of living in supportive families: a prospective analysis of high risk African-American female teens. Am J Health Promot. 2002;16:142-145.
46. Reilly T, Woo G. Social support and maintenance of safer sex practices among people living with HIV/AIDS. Health Soc Work. 2004;29:97-105.
47. Prado G, Feaster DJ, Schwartz SJ, et al. Religious involvement, coping, social support, and psychological distress in HIV-seropositive African American mothers. AIDS Behav. 2004;8:221-235.
48. Mizuno Y, Purcell D, Borkowski TM, et al. The life priorities of HIV-seropositive injection drug users: findings from a community-based sample. AIDS Behav. 2003;7:395-403.
49. Samuels JF, Vlahov D, Anthony JC, et al. Measurement of HIV risk behaviors among intravenous drug users. Br J Addict. 1992;87:417-428.
50. Macalino GE, Celentano DD, Latkin C, et al. Risk behaviors by audio computer-assisted self-interviews among HIV-seropositive and HIV-seronegative injection drug users. AIDS Educ Prev. 2002;14:367-378.
51. McIver JP, Carmines EG. Unidimensional Scaling. Thousand Oaks: Sage Publications; 1981.
52. Gliem JA, Gliem RR. Calculating, interpreting and reporting Cronbach's alpha reliability coefficient for Likert-type scales. Midwest Research to Practice Conference in Adult, Continuing and Community Education, 2003. 10-8-2003.